@article{5a6e34a73ff444a685ad0bf04f3cef71,
title = "Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia",
author = "Susie Hu and Shearer, \{Gregory C.\} and Steffes, \{Michael W.\} and Harris, \{William S.\} and Bostom, \{Andrew G.\}",
note = "Funding Information: Support: Funding for the phosphorus assays was provided by a grant to Dr Hu from the Brown University Foundation for Health , project no. 8791 . The parent study, Niacin, n-3 Fatty Acids and Insulin Resistance ( ClinicalTrials.gov registration no. NCT00286234 ), was funded through a National Institute of Diabetes and Digestive and Kidney Diseases grant to Dr Harris. Placebos and pharmaceuticals were provided by Abbott Laboratories and GlaxoSmithKline. Dr Shearer receives research support from GlaxoSmithKline . ",
year = "2011",
month = jan,
doi = "10.1053/j.ajkd.2010.06.029",
language = "English (US)",
volume = "57",
pages = "181--182",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders",
number = "1",
}